Follow the Biora Therapeutics, INC. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Biora Therapeutics, INC. has recorded 50 public disclosures. Market capitalisation: €777.3bn. The latest transaction was filed on 16 August 2024 (Retenue fiscale). Among the most active insiders: NEUMANN CLARKE. All data is openly available.
50
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
€4,470
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biora Therapeutics, INC. Strong Buy (bullish), based on 41 analysts. Average price target: US$584.24.
29Σ signal
Buys ·€4,470 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,659 of 25,750 companies
58.2
score / 100
Value
38
Quality
78
FCF yld0.2%
Earn yld0.8%
EV/EBITDA·
ROE40%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.